‘Smart drug’ modafinil helps patients recover from depression

depression modafinil

A study published by the University of Cambridge reveals that the drug modafinil can improve memory in patients recovering from depression. Currently, treatments for depression do not address the condition’s cognitive deficits. Researchers examined one cognitive deficit in particular: impaired memory.

What is modafinil?

Modafinil (marketed as Provigil) is used to treat narclopesy: excessive daytime sleepiness. Modafinil is able to fight fatigue and promote alertness and concentration. For this reason, some people have used it as a ‘smart drug’: a substance that improves mental functions. And it’s really popular among students.

A couple of years ago, a survey published by The Tab showed that one in four students at Oxford University had used it to boost performance for revising and exams. Students at Oxford University used it the most. On average, one in five students at UK universities had used it. And of those that had used it, 20% admitted taking it daily.

The Canary previously reported on the risks and ethical implications of using modafinil as a ‘smart drug’. But research has also concluded that:

Modafinil seems to be the first ‘smart drug’ that is reasonably safe for healthy people.

Researchers also noted few side effects and no addictive qualities. It was found to be safe in the short-term, although information on long-term use is limited.

A promising treatment for depression

These same researchers from the University of Cambridge published a paper a month ago, highlighting cognition as a treatment target in depression. Impaired memory has an association with poorer clinical outcomes. These include difficulties with work and increased risk of relapse.

Read on...

Depression can sometimes lead to ‘presenteeism’: being present at one’s place of work for more hours than required. This is because patients recovering from depression and returning to work may not be able to work as well as usual. This can create a vicious cycle, as presenteeism itself creates negative mental health outcomes.

This new study demonstrates that patients given modafinil experienced improvements in memory, compared to those given a placebo. There were improvements in both episodic memory (i.e. remembering what you ate for breakfast) and working memory (i.e. recalling the steps of a recipe while cooking a meal).

Lead author Dr Muzaffer Kaser remarked that the “results are very promising”. He added that modafinil “may be a feasible option to tackle persistent cognitive problems in depression”. But it will require more evidence to get to grips with modafinil’s long-term effects on depression. Professor Barbara Sahakian said:

We now need a longer term study using modafinil to see if the drug, which improves cognition and motivation, can facilitate successful return to work following depression.

People returning to work while recovering from mental health issues face many challenges. Mixed anxiety and depression is the most common mental health condition in the UK. So if modafinil can aid in recovery from depression, it could drastically improve the quality of life for many people in this country.

Get Involved!

– Support Mind, the Mental Health Foundation and Time to Change.

– Read more articles from The Canary related to mental health.

Featured image via PublicDomainPictures

We need your help to keep speaking the truth

Every story that you have come to us with; each injustice you have asked us to investigate; every campaign we have fought; each of your unheard voices we amplified; we do this for you. We are making a difference on your behalf.

Our fight is your fight. You’ve supported our collective struggle every time you gave us a like; and every time you shared our work across social media. Now we need you to support us with a monthly donation.

We have published nearly 2,000 articles and over 50 films in 2021. And we want to do this and more in 2022 but we don’t have enough money to go on at this pace. So, if you value our work and want us to continue then please join us and be part of The Canary family.

In return, you get:

* Advert free reading experience
* Quarterly group video call with the Editor-in-Chief
* Behind the scenes monthly e-newsletter
* 20% discount in our shop

Almost all of our spending goes to the people who make The Canary’s content. So your contribution directly supports our writers and enables us to continue to do what we do: speaking truth, powered by you. We have weathered many attempts to shut us down and silence our vital opposition to an increasingly fascist government and right-wing mainstream media.

With your help we can continue:

* Holding political and state power to account
* Advocating for the people the system marginalises
* Being a media outlet that upholds the highest standards
* Campaigning on the issues others won’t
* Putting your lives central to everything we do

We are a drop of truth in an ocean of deceit. But we can’t do this without your support. So please, can you help us continue the fight?

The Canary Support us

Comments are closed